Global Longlife Hospital & Research Complete Financial Statements
In FYNone, Global Longlife Hospital & Research (GLHRL) reported revenue ₹24 Cr, net profit ₹2 Cr and EPS ₹1.80 and ROE of -8.3%. Full financial statements from FY2019 to FY2026 (8 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore GLHRL intrinsic value to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
GLHRL Revenue, Net Profit & EBITDA — Year-on-Year Growth
GLHRL YoY (March 2026 vs Period), net profit +200.0%, EBITDA +500.0%, expenses +1800.0%. For live price, earnings ratios and company overview, see GLHRL screener.
GLHRL Income Statement — Revenue, EBITDA & Net Profit
Global Longlife Hospital & Research revenue ₹24 Cr, EBITDA ₹4 Cr, net profit ₹2 Cr, EPS ₹1.80 (None). Review GLHRL earnings valuation to evaluate earnings-based valuation against sector peers.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 0 | 6 | 14 | 24 | 33 | 33 | 34 | 35 |
| Expenses | 19 | 1 | 5 | 14 | 20 | 25 | 27 | 30 | 28 |
| EBITDA | 4 | -1 | 1 | 0 | 4 | 8 | 6 | 4 | 7 |
| Operating Profit Margin % | 9.00% | 0.00% | -720.00% | -2.00% | 17.00% | 24.00% | 17.00% | 10.00% | 20.00% |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 |
| Profit Before Tax | 3 | -1 | 0 | -2 | 3 | 6 | 2 | -1 | 3 |
| Tax | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| Net Profit | 2 | -2 | 0 | -2 | 2 | 4 | 2 | -1 | 1 |
| Earnings Per Share (₹) | 1.80 | -1.64 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 1.95 |
GLHRL Balance Sheet — Assets, Liabilities & Shareholders' Equity
GLHRL total assets ₹24 Cr, total equity ₹24 Cr, total liabilities ₹ Cr (2026) — ROE -8.3%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Total Assets | 24 | 27 | 42 | 76 | 34 | 37 | 42 | 43 |
| Current Assets | 20 | 23 | 4 | 34 | 11 | 12 | 16 | 15 |
| Fixed Assets | 0 | 0 | 17 | 17 | 17 | 18 | 19 | 20 |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 27 | 25 | 58 | 17 | 19 | 23 | 23 |
| LIABILITIES | ||||||||
| Total Liabilities | ||||||||
| Current Liabilities | 0 | 0 | 4 | 4 | 3 | 13 | 17 | 18 |
| Non-Current Liabilities | ||||||||
| SHAREHOLDERS' EQUITY | ||||||||
| Total Equity | 24 | 27 | 26 | 64 | 17 | 14 | 12 | 12 |
| Share Capital | 11 | 11 | 11 | 11 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 13 | 16 | 15 | 54 | 10 | 7 | 5 | 5 |
GLHRL Cash Flow Statement — Operating, Investing & Financing
Global Longlife Hospital & Research operating cash flow ₹12 Cr, investing ₹22 Cr, financing ₹-13 Cr, net cash flow ₹21 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | 12 | -5 | -40 | 9 | 7 | 4 | 5 |
| Investing Activities | 22 | -1 | -2 | 0 | 0 | 0 | 0 |
| Financing Activities | -13 | 3 | 46 | -10 | -7 | -3 | -5 |
| Net Cash Flow | 21 | -3 | 3 | 0 | 0 | 1 | 0 |